These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 2190607)
1. Sensitivity of six commercial enzyme immunoassay kits that detect both anti-HIV-1 and anti-HIV-2. Parry JV; McAlpine L; Avillez MF AIDS; 1990 Apr; 4(4):355-60. PubMed ID: 2190607 [TBL] [Abstract][Full Text] [Related]
2. Thirteen current anti-HIV-1/HIV-2 enzyme immunoassays: how accurate are they? McAlpine L; Gandhi J; Parry JV; Mortimer PP J Med Virol; 1994 Feb; 42(2):115-8. PubMed ID: 8158104 [TBL] [Abstract][Full Text] [Related]
3. Efficacies of US Food and Drug Administration-licensed HIV-1-screening enzyme immunoassays for detecting antibodies to HIV-2. George JR; Rayfield MA; Phillips S; Heyward WL; Krebs JW; Odehouri K; Soudre R; De Cock KM; Schochetman G AIDS; 1990 Apr; 4(4):321-6. PubMed ID: 2350452 [TBL] [Abstract][Full Text] [Related]
4. Multicenter evaluation of a new recombinant enzyme immunoassay for the combined detection of antibody to HIV-1 and HIV-2. Ayres L; Avillez F; Garcia-Benito A; Deinhardt F; Gürtler L; Denis F; Léonard G; Ranger S; Grob P; Joller-Jemelka H AIDS; 1990 Feb; 4(2):131-8. PubMed ID: 2183814 [TBL] [Abstract][Full Text] [Related]
5. [New methods of interlaboratory monitoring of HIV-1 ELISA kits. Comparative study of 2 periods: 1/12/1988 to 15/4/1989 and 15/4/1989 to 31/8/1989. Le Groupe Rétrovirus de la Sociètè Nationale de Transfusion Sanguine]. North ML; Noël L; Couroucé AM Rev Fr Transfus Hemobiol; 1990 Jun; 33(3):211-22. PubMed ID: 2206168 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of commercial enzyme immunoassays for anti-HIV-1 using East African sera. Bredberg-Rådén U; Kiango J; Mhalu F; Biberfeld G AIDS; 1988 Aug; 2(4):281-5. PubMed ID: 3140834 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of screening kits for the detection of anti-human immunodeficiency virus type 1 and 2 (HIV-1/2) antibodies. Chin LT; Yang BS; Chen JW; Yang CM; Chou CC; Li L; Hung CM; Tsai SJ; Lin KS Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1995 Aug; 28(3):179-92. PubMed ID: 9774997 [TBL] [Abstract][Full Text] [Related]
8. Reactivity of a new HIV-1 group O third generation A-HIV-1/-2 assay with an unusual HIV-1 seroconversion panel and HIV-1 group O/group M subtyped samples. van Binsbergen J; Keur W; vd Graaf M; Siebelink A; Jacobs A; de Rijk D; Toonen J; Zekeng L; Afane Ze E; Gürtler LG J Virol Methods; 1997 Dec; 69(1-2):29-37. PubMed ID: 9504748 [TBL] [Abstract][Full Text] [Related]
9. Multisite evaluation of four anti-HIV-1/HIV-2 enzyme immunoassays. Australian HIV Test Evaluation Group. Silvester C; Healey DS; Cunningham P; Dax EM J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):411-9. PubMed ID: 7882108 [TBL] [Abstract][Full Text] [Related]
10. Performance of six different commercial assays to demonstrate antibodies to HIV-2 among immigrants from high-endemic areas. Skaug K; Ulstrup JC; Espinoza R Scand J Infect Dis; 1990; 22(3):373-4. PubMed ID: 2371550 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay. Chavez P; Wesolowski L; Patel P; Delaney K; Owen SM J Clin Virol; 2011 Dec; 52 Suppl 1():S51-5. PubMed ID: 21983253 [TBL] [Abstract][Full Text] [Related]
12. [Strip immunoblot assay (SIA) with recombinant antigens and synthetic peptide for detection of anti HIV-1 and HIV-2 antibodies]. Deguchi M; Yamashita N; Kagita M; Asari S; Yanagihara T Kansenshogaku Zasshi; 2001 May; 75(5):371-81. PubMed ID: 11424486 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel. Thorstensson R; Andersson S; Lindbäck S; Dias F; Mhalu F; Gaines H; Biberfeld G J Virol Methods; 1998 Feb; 70(2):139-51. PubMed ID: 9562408 [TBL] [Abstract][Full Text] [Related]
14. Performance characteristics of recombinant enzyme immunoassay to detect antibodies to human immunodeficiency virus type 1 (HIV-1) and HIV-2 and to measure early antibody responses in seroconverting patients. Galli RA; Castriciano S; Fearon M; Major C; Choi KW; Mahony J; Chernesky M J Clin Microbiol; 1996 Apr; 34(4):999-1002. PubMed ID: 8815130 [TBL] [Abstract][Full Text] [Related]
15. Detection of human immunodeficiency virus type 1 and type 2 antibodies by a new automated microparticle immunoassay AxSYM HIV-1/HIV-2. Weber B; Behrens N; Doerr HW J Virol Methods; 1997 Jan; 63(1-2):137-43. PubMed ID: 9015284 [TBL] [Abstract][Full Text] [Related]
16. Propylene glycol interference in the Vidas HIV DUO assay. Ferrer-Cañabate J; Agulló-Ortuño T; García-Mancebo ML; Real-Panisello M; Martínez-Hernández P; Noguera-Velasco JA Clin Biochem; 2002 Jun; 35(4):333-4. PubMed ID: 12135698 [No Abstract] [Full Text] [Related]
17. The use of simple, rapid tests to detect antibodies to human immunodeficiency virus types 1 and 2 in pooled serum specimens. Soroka SD; Granade TC; Phillips S; Parekh B J Clin Virol; 2003 May; 27(1):90-6. PubMed ID: 12727534 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the sensitivity of four rapid assays for the detection of antibodies to HIV-1/HIV-2 during seroconversion. Samdal HH; Gutigard BG; Labay D; Wiik SI; Skaug K; Skar AG Clin Diagn Virol; 1996 Oct; 7(1):55-61. PubMed ID: 9077430 [TBL] [Abstract][Full Text] [Related]
19. [Specificity of a new test for detection of antibodies to HIV-1/-2 in blood donors]. Saadé C; Wüst T Infusionsther Transfusionsmed; 1996 Jun; 23(3):133-7. PubMed ID: 8924748 [TBL] [Abstract][Full Text] [Related]
20. Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays. Kwon JA; Yoon SY; Lee CK; Lim CS; Lee KN; Sung HJ; Brennan CA; Devare SG J Virol Methods; 2006 Apr; 133(1):20-6. PubMed ID: 16313975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]